206 related articles for article (PubMed ID: 24893185)
1. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.
Silva A; Rauscher GH; Ferrans CE; Hoskins K; Rao R
J Registry Manag; 2014; 41(1):24-30. PubMed ID: 24893185
[TBL] [Abstract][Full Text] [Related]
2. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
3. Comparing Cancer Registry Abstracted and Self-Reported Data on Race and Ethnicity.
Atekruse SF; Cosgrove C; Cronin K; Yu M
J Registry Manag; 2017; 44(1):30-3. PubMed ID: 29595942
[TBL] [Abstract][Full Text] [Related]
4. Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews.
Du XL; Key CR; Dickie L; Darling R; Delclos GL; Waller K; Zhang D
J Clin Epidemiol; 2006 Jan; 59(1):53-60. PubMed ID: 16360561
[TBL] [Abstract][Full Text] [Related]
5. Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data.
Schootman M; Jeffe DB; West MM; Aft R
J Clin Epidemiol; 2005 Dec; 58(12):1316-9. PubMed ID: 16291477
[TBL] [Abstract][Full Text] [Related]
6. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
7. Implications of missing data on reported breast cancer mortality.
Plichta JK; Rushing CN; Lewis HC; Rooney MM; Blazer DG; Thomas SM; Hwang ES; Greenup RA
Breast Cancer Res Treat; 2023 Jan; 197(1):177-187. PubMed ID: 36334190
[TBL] [Abstract][Full Text] [Related]
8. Validity of cancer registry data for measuring the quality of breast cancer care.
Malin JL; Kahn KL; Adams J; Kwan L; Laouri M; Ganz PA
J Natl Cancer Inst; 2002 Jun; 94(11):835-44. PubMed ID: 12048271
[TBL] [Abstract][Full Text] [Related]
9. Collecting information on race, Hispanic ethnicity, and birthplace of cancer patients: policies and practices in Connecticut hospitals.
Polednak AP
Ethn Dis; 2005; 15(1):90-6. PubMed ID: 15720054
[TBL] [Abstract][Full Text] [Related]
10. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
11. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
12. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status.
Churilla TM; Egleston B; Bleicher R; Dong Y; Meyer J; Anderson P
Breast J; 2017 Mar; 23(2):169-176. PubMed ID: 27797159
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?
Ma H; Wang Y; Sullivan-Halley J; Weiss L; Burkman RT; Simon MS; Malone KE; Strom BL; Ursin G; Marchbanks PA; McDonald JA; Spirtas R; Press MF; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2214-20. PubMed ID: 19661080
[TBL] [Abstract][Full Text] [Related]
14. Using hospital medical record data to assess the accuracy of the SEER Los Angeles Cancer Surveillance Program for initial treatment of prostate cancer: a small pilot study.
Kraus RD; Hamilton AS; Carlos M; Ballas LK
Cancer Causes Control; 2018 Sep; 29(9):815-821. PubMed ID: 30022335
[TBL] [Abstract][Full Text] [Related]
15. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies.
Clegg LX; Reichman ME; Hankey BF; Miller BA; Lin YD; Johnson NJ; Schwartz SM; Bernstein L; Chen VW; Goodman MT; Gomez SL; Graff JJ; Lynch CF; Lin CC; Edwards BK
Cancer Causes Control; 2007 Mar; 18(2):177-87. PubMed ID: 17219013
[TBL] [Abstract][Full Text] [Related]
16. Completeness of American Cancer Registry Treatment Data: implications for quality of care research.
Mallin K; Palis BE; Watroba N; Stewart AK; Walczak D; Singer J; Barron J; Blumenthal W; Haydu G; Edge SB
J Am Coll Surg; 2013 Mar; 216(3):428-37. PubMed ID: 23357724
[TBL] [Abstract][Full Text] [Related]
17. Agreement between electronic medical records and self-reported urologic domains in the National Spina Bifida Patient Registry (NSBPR): Implications for future research.
Halline CG; Meyer T; Rosoklija I; Yerkes EB
J Pediatr Urol; 2017 Aug; 13(4):390.e1-390.e6. PubMed ID: 28655526
[TBL] [Abstract][Full Text] [Related]
18. How generalizable are the SEER registries to the cancer populations of the USA?
Kuo TM; Mobley LR
Cancer Causes Control; 2016 Sep; 27(9):1117-26. PubMed ID: 27443170
[TBL] [Abstract][Full Text] [Related]
19. Assessing race and ethnicity data quality across cancer registries and EMRs in two hospitals.
Lee SJ; Grobe JE; Tiro JA
J Am Med Inform Assoc; 2016 May; 23(3):627-34. PubMed ID: 26661718
[TBL] [Abstract][Full Text] [Related]
20. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Kim HM; Goodman M; Kim BI; Ward KC
J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
